Sonic Healthcare Ltd
SHL
Company Profile
Business description
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 40% of group revenue in Australia and New Zealand, 25% in the US, and 35% in Europe.
Contact
225 George Street
Level 22, Grosvenor Place
SydneyNSW2000
AUST: +61 298555444
E: ContactUs@sonichealthcare.com.au
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
30 June 2025
Employees
41,000
Sonic Healthcare Ltd News & Analysis
personal-finance
Top 8 ASX dividend shares
These undervalued shares with moats have attractive and potentially growing dividends.
stocks
Have some of the ASX 200's worst performers fallen too far?
These four stocks have had an awful twelve months. Morningstar's analysts weigh in on whether they offer good value yet.
stocks
Market is underestimating ASX pathology shares
Morningstar sees several reasons to expect a stronger recover than market consensus.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,453.90 | 22.40 | -0.26% |
| CAC 40 | 7,549.12 | 51.64 | 0.69% |
| DAX 40 | 19,549.86 | 172.24 | 0.89% |
| Dow JONES (US) | 42,514.95 | 409.94 | -0.96% |
| FTSE 100 | 8,309.08 | 50.44 | 0.61% |
| HKSE | 20,489.62 | 270.53 | -1.30% |
| NASDAQ | 18,276.65 | 296.47 | -1.60% |
| Nikkei 225 | 38,143.29 | 38.43 | 0.10% |
| NZX 50 Index | 12,814.07 | 26.47 | 0.21% |
| S&P 500 | 5,797.42 | 0.00 | 0.00% |
| S&P/ASX 200 | 8,206.30 | 9.70 | -0.12% |
| SSE Composite Index | 3,280.26 | 22.54 | -0.68% |